Michael Gelband’s Cardiovascular Systems, Inc. CSII Stock Holding History

Michael Gelband’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,957	Closed	-$237K	–	2369
2023 Q1	$237K	Buy	+11,957	New	+$206K	﹤0.01%	1533
2022 Q3	–	Sell	-22,851	Closed	-$328K	–	2447
2022 Q2	$328K	Buy	+22,851	New	+$396K	﹤0.01%	1502
2022 Q1	–	Sell	-26,923	Closed	-$506K	–	2810
2021 Q4	$506K	Buy	26,923 +12,423	+86%	+$332K	0.01%	1392
2021 Q3	$476K	Buy	+14,500	New	+$541K	0.01%	1428
2020 Q3	–	Sell	-18,824	Closed	-$594K	–	2363
2020 Q2	$594K	Buy	+18,824	New	+$703K	0.02%	991

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Michael Gelband's CSII Position: Q2 2023 in Review

Michael Gelband sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 11,957 shares — an estimated $237K sold.

Michael Gelband first reported a position in CSII in Q2 2020 and held it in 5 quarters. The position peaked at $594K in Q2 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Michael Gelband reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Michael Gelband sold 11,957 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $237K.
Michael Gelband first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 5 quarters.
Michael Gelband's Cardiovascular Systems, Inc. position peaked at $594K in Q2 2020.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.